(PRWEB) March 06, 2013
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that the company will present at Drug, Chemical and Associated Technologies Association (DCAT) week in New York City, NY.
A presentation “Key Trends for Sterile Injectable Manufacturing and Outsourcing” will be given by Tony Pidgeon, Senior Manager, Global Science and Technology, Patheon Inc. on Wednesday, March 13, 2013 at 9 a.m. Eastern Time. The discussion will focus on trends and steps that are being taken by contract manufacturing organizations, as well as branded and generic pharmaceutical companies, to improve operational security while retaining competitiveness. Visit http://www.patheon.com for more information.
Patheon executives will also be available to meet during DCAT week from March 11-14, 2013. To schedule a meeting in advance send an email to events(at)patheon(dot)com.
Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.
Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.
Read the full story at http://www.prweb.com/releases/2013/3/prweb10495185.htm.
Copyright©2012 Vocus, Inc.
All rights reserved